lactate dehydrogenase

You have access
Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer
MOTOHIRO FUJIWARA, RYO FUJIWARA, TETSUYA URASAKI, TOMOHIKO OGUCHI, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, JUNJI YONESE and TAKESHI YUASA

Anticancer Research April 2022, 42 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.15685
You have access
Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer
LEANDRO BLAS, MASAKI SHIOTA, SHIGETOMO YAMADA, KOSUKE IEIRI, SHOHEI NAGAKAWA, SHIGEHIRO TSUKAHARA, TAKASHI MATSUMOTO, EIJI KASHIWAGI, ARIO TAKEUCHI, JUNICHI INOKUCHI, KEN-ICHIRO SHIGA, AKIRA YOKOMIZO and MASATOSHI ETO

Anticancer Research August 2021, 41 (8) 3885-3889; DOI: https://doi.org/10.21873/anticanres.15183
You have access
Lactate Dehydrogenase Is a Useful Marker for Predicting the Efficacy of Bevacizumab-containing Chemotherapy in Patients With Metastatic Colorectal Cancer
MASATSUNE SHIBUTANI, KIYOSHI MAEDA, SHINICHIRO KASHIWAGI, HISASHI NAGAHARA, TATSUNARI FUKUOKA, YASUHITO ISEKI, EN WANG, YUKI OKAZAKI, KOSEI HIRAKAWA and MASAICHI OHIRA

Anticancer Research July 2021, 41 (7) 3535-3542; DOI: https://doi.org/10.21873/anticanres.15141
You have access
Is Serum Lactate Dehydrogenase Useful for Predicting Oncological Outcome in Patients With Soft Tissue Sarcoma?
TOMOKI NAKAMURA, KUNIHIRO ASANUMA, TOMOHITO HAGI and AKIHIRO SUDO

Anticancer Research December 2019, 39 (12) 6871-6875; DOI: https://doi.org/10.21873/anticanres.13905
You have access
Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma
SUGURU SHIROTAKE, KIMIHARU TAKAMATSU, RYUICHI MIZUNO, GO KANEKO, KOSHIRO NISHIMOTO, MOTOTSUGU OYA and MASAFUMI OYAMA

Anticancer Research August 2019, 39 (8) 4371-4377; DOI: https://doi.org/10.21873/anticanres.13606
You have access
Local Control and Clinical Outcome of High-risk Pediatric Neuroblastoma Patients After Receiving Multimodality Treatment and Helical Tomotherapy
GUANN-YIING CHEN, JASON CHIA-HSIEN CHENG, YU-HSUAN CHEN, MENG-YAO LU, HSIU-HAO CHANG, YUNG-LI YANG, SHIANN-TARNG JOU, WEN-MING HSU and SUNG-HSIN KUO

Anticancer Research April 2019, 39 (4) 2207-2215; DOI: https://doi.org/10.21873/anticanres.13336
You have access
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib
ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, ONDREJ TOPOLCAN, JAROSLAV RACEK, MARTIN SVATON, RADEK KUCERA, MAREK MINARIK, LUCIE BENESOVA, ZBYNEK BORTLICEK, RENATA CHLOUPKOVA, ALEXANDR POPRACH and TOMAS BUCHLER

Anticancer Research May 2016, 36 (5) 2459-2465;
You have access
Inhibition of Growth by Combined Treatment with Inhibitors of Lactate Dehydrogenase and either Phenformin or Inhibitors of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase 3
MICHAEL A. LEA, YOLANDA GUZMAN and CHARLES DESBORDES

Anticancer Research April 2016, 36 (4) 1479-1488;

Main menu

User menu

Search

lactate dehydrogenase